Chi‐Fong Lin

581 total citations
29 papers, 514 citations indexed

About

Chi‐Fong Lin is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Chi‐Fong Lin has authored 29 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 13 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Chi‐Fong Lin's work include Cyclization and Aryne Chemistry (20 papers), Catalytic Alkyne Reactions (11 papers) and Chemical synthesis and alkaloids (8 papers). Chi‐Fong Lin is often cited by papers focused on Cyclization and Aryne Chemistry (20 papers), Catalytic Alkyne Reactions (11 papers) and Chemical synthesis and alkaloids (8 papers). Chi‐Fong Lin collaborates with scholars based in Taiwan. Chi‐Fong Lin's co-authors include Ming‐Jung Wu, Chia‐Ying Lee, Ming-Chu Hsieh, Jeh‐Jeng Wang, Yi‐Hua Chen, Pei‐Chen Hsieh, Chi Wi Ong, Sheng‐Huei Yang, Shinne‐Ren Lin and Tsai‐Hui Duh and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Chi‐Fong Lin

29 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Fong Lin Taiwan 14 483 111 28 26 16 29 514
Carme Masdeu Spain 14 390 0.8× 138 1.2× 16 0.6× 24 0.9× 14 0.9× 23 437
David S. Ennis United Kingdom 11 329 0.7× 81 0.7× 26 0.9× 11 0.4× 21 1.3× 19 360
Dawn Taylor United Kingdom 6 282 0.6× 70 0.6× 22 0.8× 14 0.5× 6 0.4× 8 333
Wilm Buhr Germany 12 298 0.6× 121 1.1× 38 1.4× 13 0.5× 6 0.4× 15 366
Kachigere B. Harsha India 9 272 0.6× 82 0.7× 16 0.6× 23 0.9× 9 0.6× 26 319
Timothy C. Walsgrove United Kingdom 12 233 0.5× 97 0.9× 13 0.5× 11 0.4× 7 0.4× 21 274
Stephy Elza John India 11 489 1.0× 102 0.9× 38 1.4× 13 0.5× 16 1.0× 17 526
José L. García‐Navío Spain 13 413 0.9× 179 1.6× 14 0.5× 11 0.4× 24 1.5× 21 447
Keshri Nath Tiwari India 10 355 0.7× 82 0.7× 50 1.8× 56 2.2× 11 0.7× 21 376
Maneesh Kashyap India 10 418 0.9× 89 0.8× 25 0.9× 12 0.5× 39 2.4× 13 462

Countries citing papers authored by Chi‐Fong Lin

Since Specialization
Citations

This map shows the geographic impact of Chi‐Fong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Fong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Fong Lin more than expected).

Fields of papers citing papers by Chi‐Fong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Fong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Fong Lin. The network helps show where Chi‐Fong Lin may publish in the future.

Co-authorship network of co-authors of Chi‐Fong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Fong Lin. A scholar is included among the top collaborators of Chi‐Fong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Fong Lin. Chi‐Fong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, I‐Ling, et al.. (2008). Design and Synthesis of 1‐(6‐(2‐(2‐Arylethynyl)Phenyl)Hexyn‐5‐yl)Piperidin‐2‐Ones as Antitumor Agents that Induce Apoptotic Progress. Journal of the Chinese Chemical Society. 55(3). 668–674. 2 indexed citations
2.
Lin, I‐Ling, et al.. (2007). Novel acyclic enediynes inhibit Cyclin A and Cdc25C expression and induce apoptosis phenomenon to show potent antitumor proliferation. Bioorganic & Medicinal Chemistry. 15(13). 4528–4536. 12 indexed citations
3.
Lin, Chi‐Fong, et al.. (2005). Cytotoxicities, cell cycle and caspase evaluations of 1,6-diaryl-3(Z)-hexen-1,5-diynes, 2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines and their derivatives. Bioorganic & Medicinal Chemistry. 13(10). 3565–3575. 34 indexed citations
4.
Lin, Chi‐Fong, et al.. (2004). Remarkable G2/M phase arrest and apoptotic effect performed by 2-(6-aryl-3-hexen-1,5-diynyl) benzonitrile antitumor agents. Bioorganic & Medicinal Chemistry. 12(5). 1047–1053. 9 indexed citations
5.
Lee, Chia‐Ying, et al.. (2004). Synthesis of Carbazoles via an Intramolecular Cyclization of 2-(6-Substituted 3(Z)-hexen-1,5-diynyl)anilines and Their Related Molecules. The Journal of Organic Chemistry. 69(6). 2106–2110. 35 indexed citations
7.
Lin, Chi‐Fong, et al.. (2004). Substituent effects on the cyclization mode of 7-sulfonyl-3-hepten-1,5-diynes and 11-sulfonylundeca-3,7-dien-1,5,9-triynes. Tetrahedron. 60(17). 3927–3934. 14 indexed citations
8.
Chuang, Lea‐Yea, Jinn‐Yuh Guh, Shufen Liu, et al.. (2003). Regulation of type II transforming-growth-factor-β receptors by protein kinase C ι. Biochemical Journal. 375(2). 385–393. 15 indexed citations
9.
Wu, Ming‐Jung, Chia‐Ying Lee, & Chi‐Fong Lin. (2002). A Route to 5-Substituted Dibenzofurans by Anionic Cycloaromatization of 2-(6-substituted 3-hexen-1,5-diynyl)phenyl tert-butyldimethyl ethers and Related Molecules. Angewandte Chemie International Edition. 41(21). 4077–4079. 25 indexed citations
10.
Lin, Chi‐Fong, et al.. (2002). Substituent effect on anionic cycloaromatization of 2-(2-substituted ethynyl)benzonitriles and related molecules. Tetrahedron. 58(36). 7315–7319. 41 indexed citations
12.
Wu, Ming‐Jung, et al.. (2002). Anionic Cycloaromatization of 1-Aryl-3-hexen-1,5-diynes Initiated by Methoxide Addition:  Synthesis of Phenanthridinones, Benzo[c]phenanthridinones, and Biaryls. The Journal of Organic Chemistry. 67(17). 5907–5912. 26 indexed citations
13.
Lin, Chi‐Fong, et al.. (2001). A Series of Enediynes as Novel Inhibitors of Topoisomerase I. Bioorganic & Medicinal Chemistry. 9(7). 1707–1711. 15 indexed citations
14.
Lin, Chi‐Fong, et al.. (2001). Solvent Effects on Aza‐anionic Cycloaromatization of 2‐(2‐Substituted‐ethynyl)benzonitriles. Journal of the Chinese Chemical Society. 48(2). 211–214. 3 indexed citations
16.
Lin, Chi‐Fong, et al.. (2000). Palladium-catalyzed coupling of aryl iodides with 2-alkynylbenzonitriles. Tetrahedron Letters. 41(8). 1215–1218. 26 indexed citations
17.
Wu, Ming‐Jung, et al.. (1999). Thermolysis of 2-(3-phenylsulfonylprop-1-ynyl)benzonitrile: an aza-Myers type cyclization to isoquinolines. Journal of the Chemical Society Perkin Transactions 1. 2875–2876. 7 indexed citations
18.
Wu, Ming‐Jung, et al.. (1998). Allene‐Eneyne Related Cycloaromatization: Design and Synthesis of New DNA‐Cleaving Compounds. Journal of the Chinese Chemical Society. 45(4). 475–479. 1 indexed citations
19.
Wu, Ming‐Jung, et al.. (1996). Molecular design, chemical synthesis and biological studies of novel enediynes related to dynemicin a. Bioorganic & Medicinal Chemistry Letters. 6(18). 2183–2186. 12 indexed citations
20.
Wu, Ming‐Jung, et al.. (1994). Biradical formation from molecules with (Z)-7-sulfonyl-3-hexen-1,5-diyne functionalities. Tetrahedron Letters. 35(12). 1879–1882. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026